There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...
Gilead Sciences (NASDAQ:GILD) has discontinued a Phase 1 trial for GS-1219, a long-acting subcutaneously delivered treatment ...
Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first ...
President Joe Biden's administration has approved a new rule allowing organ transplants from HIV-positive donors to HIV-positive recipients, U.S. health officials announced on Tuesday. The decision ...
Despite decades of research and several important breakthroughs, Human Immunodeficiency Virus (HIV) remains a prominent public health threat with no cure which has to this point claimed roughly 40 ...
Research from the CHEETAH Center investigating human immunodeficiency virus (HIV) is providing valuable insights into how the virus works and is leading to new types of therapeutic interventions. A ...
We might be a step closer to curing HIV, as researchers have developed a way to knock out a version of the virus lurking in the body. Using something called an HIV-like particle (HLP)—which are dead ...
If you’re a drug developer, HIV is nothing but a thief. All the virus wants to do is break inside a healthy cell, steal its genetic machinery, and start profiting from the intrusion. To stop a thief, ...
According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback